Skip to main content
. 2024 Jul 2;18:2681–2692. doi: 10.2147/DDDT.S454314

Table 3.

Comparison of Adverse Effects

EP Group (n=60) R Group (n=60) Total (n=120) P value
Hiccups (n, %) 0 8 (13.3%) 8 (6.7%) 0.003
Hypoxia (n, %) 3 (5.0%) 1 (1.7%) 4 (3.3%) 0.310
Depression of respiration (n, %) 6 (10.0%) 1 (1.7%) 7 (5.8%) 0.051
Tongue falling (n, %) 2 (3.3%) 1 (1.7%) 3 (2.5%) 0.559
Total respiratory-related adverse events (n, %) 11 (18.3%) 3 (5.0%) 14 (11.7%) 0.047
Choking cough (n, %) 0 (0.0%) 3 (5.0%) 3 (2.5%) 0.080
Movement of the body (n, %) 2 (3.3%) 1 (1.7%) 3 (2.5%) 0.559
Low blood pressure (n, %) 22 (36.7%) 24 (40%) 46 (38.33%) 0.851
Nausea (n, %) 1 (1.7%) 1 (1.7%) 2 (1.7%) 1
Dizziness (n, %) 1 (1.7%) 0 (0%) 1 (0.8%) 1